Zachary Singer, | |
6425 W Mequon Rd, Mequon, WI 53092-1855 | |
(262) 242-0051 | |
(262) 236-8780 |
Full Name | Zachary Singer |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 11 Years |
Location | 6425 W Mequon Rd, Mequon, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225371727 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 65416-021 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Aurora Medical Center - Grafton | Grafton, WI | Hospital |
Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aurora Advanced Healthcare Inc | 3375625833 | 929 |
News Archive
Patients battling to deal with the eating disorder anorexia nervosa, do not benefit or prevent relapses of the life-threatening eating disorder by taking the anti-depressant Prozac.
The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) continues its 25-year mission to alleviate the suffering of mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.
The use of coercive measures in psychiatric care has decreased over the past years. However, a new study shows that coercive measures are still frequently used in Finland, and periods of both seclusion and mechanical restraint are long.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the market entry of novel angiogenic agents, including a future blockbuster drug from Genzyme, could revolutionize symptomatic treatment of peripheral arterial disease (PAD).
› Verified 9 days ago
Entity Name | Aurora Advanced Healthcare Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
Patients battling to deal with the eating disorder anorexia nervosa, do not benefit or prevent relapses of the life-threatening eating disorder by taking the anti-depressant Prozac.
The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) continues its 25-year mission to alleviate the suffering of mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.
The use of coercive measures in psychiatric care has decreased over the past years. However, a new study shows that coercive measures are still frequently used in Finland, and periods of both seclusion and mechanical restraint are long.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the market entry of novel angiogenic agents, including a future blockbuster drug from Genzyme, could revolutionize symptomatic treatment of peripheral arterial disease (PAD).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Zachary Singer, 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (262) 242-0051 | Zachary Singer, 6425 W Mequon Rd, Mequon, WI 53092-1855 Ph: (262) 242-0051 |
News Archive
Patients battling to deal with the eating disorder anorexia nervosa, do not benefit or prevent relapses of the life-threatening eating disorder by taking the anti-depressant Prozac.
The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) continues its 25-year mission to alleviate the suffering of mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.
The use of coercive measures in psychiatric care has decreased over the past years. However, a new study shows that coercive measures are still frequently used in Finland, and periods of both seclusion and mechanical restraint are long.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the market entry of novel angiogenic agents, including a future blockbuster drug from Genzyme, could revolutionize symptomatic treatment of peripheral arterial disease (PAD).
› Verified 9 days ago
Henry J Schnitzler Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12800 N Port Washington Rd, Mequon, WI 53097 Phone: 262-243-9600 | |
Krista M Dyreson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6425 W Mequon Rd, Mequon, WI 53092 Phone: 262-242-0051 | |
Dr. Mark W Niedfeldt, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10556 North Port Washington Road, Suite 101, Mequon, WI 53092 Phone: 262-643-4720 Fax: 262-643-4721 | |
Richard Lewis, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 11649 N Port Washington Rd Ste 114, Mequon, WI 53092 Phone: 262-235-3800 Fax: 262-236-9726 | |
John J Yang, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6425 W Mequon Road, Mequon, WI 53092 Phone: 262-242-0051 Fax: 262-242-8927 | |
Nicola M. Charlton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11221 N Parkview Dr, Mequon, WI 53092 Phone: 414-630-6308 |